(Q46846896)

25 December 2017

title

Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany (English)

1 reference

25 December 2017

0 references

Geyer J

1

1 reference

25 December 2017

Döring B

2

1 reference

25 December 2017

Godoy JR

3

1 reference

25 December 2017

Leidolf R

4

1 reference

25 December 2017

Moritz A

5

1 reference

25 December 2017

Petzinger E

6

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Journal of Veterinary Pharmacology and Therapeutics

published in

1 reference

25 December 2017

volume

28

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

545-551

1 reference

25 December 2017

Mammalian ABC transporters in health and disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Ivermectin: does P-glycoprotein play a role in neurotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Importance of P-glycoprotein at blood-tissue barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Ivermectin toxicity in 17 collies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of collies from France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Ivermectin excretion by isolated functionally intact brain endothelial capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

MDR1 genotype-related pharmacokinetics and pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

The physiological function of drug-transporting P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Role of P-glycoprotein in drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

MDR1 Haplotypes Modify BEN Disease Risk: A Study in Bulgarian Patients with Balkan Endemic Nephropathy Compared to Healthy Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2005.00692.X

10.1111/J.1365-2885.2005.00692.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017